DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX (Q2147506): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
(‎Changed label, description and/or aliases in de, and other parts: Adding German translations)
label / delabel / de
 
ENTWICKLUNG EINER PLATTFORM FÜR MUTANOMA IDENTIFIKATION UND PERSONALISIERTE IMPFUNG BEI KREBSPATIENTEN – PRECIVAX
Property / summary
 
BIOTECHNOLOGIE (German)
Property / summary: BIOTECHNOLOGIE (German) / rank
 
Normal rank
Property / summary: BIOTECHNOLOGIE (German) / qualifier
 
point in time: 25 December 2021
Timestamp+2021-12-25T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 11:49, 25 December 2021

Project Q2147506 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVEX
Project Q2147506 in Italy

    Statements

    0 references
    132,201.83 Euro
    0 references
    178,156.84 Euro
    0 references
    74.21 percent
    0 references
    1 November 2016
    0 references
    31 December 2018
    0 references
    UNISALERNO- DIFARMA
    0 references
    0 references

    40°44'48.98"N, 14°46'11.96"E
    0 references
    BIOTECNOLOGIE (Italian)
    0 references
    BIOTECHNOLOGY (English)
    0 references
    BIOTECHNOLOGIE (French)
    23 December 2021
    0 references
    BIOTECHNOLOGIE (Dutch)
    24 December 2021
    0 references
    BIOTECHNOLOGIE (German)
    25 December 2021
    0 references

    Identifiers

    B48I17000350008
    0 references